Agilent Brings Expanded PD-L1 Testing and Digital Pathology Workflows to USCAP 2026
The company will highlight a new PD-L1 indication for ovarian cancer and end-to-end digital pathology workflows at the annual meeting in San Antonio.
Read More
Search Results for: liver disease
Roche’s Mass Spectrometry Steroid Assays Receive FDA Moderate Complexity Designation
The Ionify steroid assay panel, which runs on the cobas i 601 analyzer, joins the previously cleared 25-Hydroxy Vitamin D total assay in Roche’s growing US mass spectrometry portfolio.
Read More
Diabetes Testing Moves Earlier—and Gets More Complex
As the 2026 ADA Standards of Care emphasize earlier identification and more precise classification of diabetes, clinical laboratories are rethinking workflows, assay menus, and their role in detection.
Read More
NeoGenomics’ PanTracer LBx Test Qualifies for Medicare Coverage Under MolDX Policy
The blood-based genomic profiling assay for advanced solid tumors is now reimbursable under Medicare’s policy covering plasma-based genomic profiling tests.
Read More
WHOOP Adds Women’s Health Blood Biomarker Panel to Its Lab Testing Lineup
The new panel includes 11 female-specific biomarkers covering hormonal transitions, thyroid function, and nutrient levels.
Read More